Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
7.75
+0.12 (1.57%)
At close: Aug 13, 2025, 4:00 PM
7.74
-0.01 (-0.13%)
After-hours: Aug 13, 2025, 4:04 PM EDT

Lifecore Biomedical Revenue

In the fiscal year ending May 25, 2025, Lifecore Biomedical had annual revenue of $128.87M with 0.47% growth. Lifecore Biomedical had revenue of $36.44M in the quarter ending May 25, 2025, a decrease of -3.81%.

Revenue (ttm)
$128.87M
Revenue Growth
+0.47%
P/S Ratio
2.09
Revenue / Employee
$245,929
Employees
524
Market Cap
289.91M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
May 25, 2025128.87M606.00K0.47%
May 26, 2024128.26M24.99M24.20%
May 28, 2023103.27M-8.00M-7.19%
May 29, 2022111.27M10.40M10.31%
May 30, 2021100.87M-59.19M-36.98%
May 31, 2020 Pro Pro Pro
May 26, 2019 Pro Pro Pro
May 27, 2018 Pro Pro Pro
May 28, 2017 Pro Pro Pro
May 29, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 422.82B
Johnson & Johnson 90.63B
Merck & Co. 63.62B
AbbVie 58.33B
AstraZeneca 56.50B
Novartis AG 55.19B
Eli Lilly and Company 53.26B
Novo Nordisk 49.11B
Revenue Rankings